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Abstract
Hyperlipidemia is a prevalent disease and a major component of the metabolic syndrome resulting from various factors. This
disease increases morbidity and mortality when combined with other prevalent diseases such as diabetes mellitus, hypertension,
and cardiovascular diseases. The side effects of the current lipid-lowering drugs have increased the tendency to move toward
traditional and alternative treatments. Epidemiological observations indicate that using alternative treatments, consumption of
medicinal plants, diet, and consumption of fruits have had satisfactory results on the effects of hyperlipidemia in many societies. It
should be noted that in majority of societies, even developed countries, the tendency toward eating lipid-lowering medicinal
plants has increased extensively. Using these plants especially when common remedies cannot control the disease is significant.
Although consumption of medicinal plants by hyperlipidemic patients may show improvement in disease state, drug interaction
and side effects may cause complications in disease control. Therefore, in this review, apart from introducing some of the reliable
plants effective in inhibition and decrease of hyperlipidemia, the possibility of their intoxication and drug interaction is also
presented.
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Nowadays, cardiovascular complications are considered as the
main factors of morbidity and mortality. Globally, the number
of deaths from cardiovascular diseases has increased from 14.4
million in 1990 to 17.5 million in 2005, and it is estimated to be
about 20 million in 2015.1 Some circulating agents such as low-
density lipoprotein free radicals, homocysteine, and nicotine
are also considered as leading factors. Morbidity and mortality
increase when combined with other prevalent diseases such as
diabetes mellitus and hypertension.2
The formation of atherosclerotic plaque involves accumula-
tion of low-density lipoprotein in intima, low-density lipopro-
tein oxidation, uptake of oxidized low-density lipoprotein by
macrophage scavenger receptors, influence of macrophages
on foam cells, and stabilization of plaque. In all steps of ather-
osclerosis, inflammatory cytokines are involved and make this
process a chronic inflammatory disease.3
When the blockage of the coronary arteries reaches more than
75%, usually the symptoms of angina will gradually appear.
Blood clot usually develops on the irregular surfaces of arteries,
which then may become detached, thus blocking the down-
stream blood flow. Heart attacks and strokes are usually caused
by such blood clots. Moreover, the atherosclerotic blood vessels
are generally weak and can burst. The best treatment in diseases
such as atherosclerosis is prevention. Therefore, conventional
medical approaches generally focus on lifestyle changes, such
as reduction in the consumption of saturated fats, quitting smok-
ing, and aerobic exercise. Drugs are also used to lower choles-
terol levels or blood pressure; however, most of them possess
considerable side effects.4
Using alternative treatments, especially medicinal plants
and their complements, to treat different diseases such as
hyperlipidemia,5-7 diabetes,7,8 and cardiovascular diseases9-12
has increased over the recent decades in majority of countries
worldwide. One of the important problems faced by doctors
and also users of medicinal plants is lack of enough informa-
tion in the field of drug safety and its effect on disease.13,14
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Fortunately, extensive studies have been done on the effective-
ness of medicinal plants used in traditional medicine over the
30 past years and some of their efficiencies and deficiency have
been recorded.15-18
This review was therefore aimed to introduce some promis-
ing medicinal plants effective in the prevention or treatment of
hyperlipidemia, apart from presenting the possibility of their
intoxication and drug interaction.
Lipid-Lowering Medicinal Plants
Different remedies are used to treat hyperlipidemia in tradi-
tional medicine in which the role of medicinal plants is signif-
icant. Recent researches performed on medicinal plants and
food supplements used in traditional medicine indicate that
compounds present in them including food fibers, vitamins, fla-
vonoids, sterols, and other antioxidant compounds can lower
lipids, inhibit low-density lipoprotein oxidation, eliminate oxy-
gen free radicals, and possibly improve this disease by having
an effect on the immune system and improving metabolic dis-
orders of the body.19-22
Cynara cardunculus (Artichoke)
In the early 20th century, French scientists stated this plant as
liver and bile stimulator. Leaves of artichoke are used as diure-
tic to stimulate kidneys and as bile stimulator to release the
flow of bile from the liver. Italian scientists used to prescribe
the cynarin compound (effective substance of artichoke) to sti-
mulate the liver and gallbladder and to treat elevated choles-
terol.23 Use of artichoke leaves stimulates bile production
and results in dyspeptic problems being treated. There are no
valid evidences indicating that leaves of this plant treat dyspep-
tic problems directly.24 A number of animal studies suggest
that artichoke leaves inhibit cholesterol synthesis in liver cells
and also protect the liver from damages caused by chemical
toxins.25 According to a study performed on 143 patients with
high cholesterol, leaves of artichoke improved the level of cho-
lesterol significantly.26 In this randomized, double-blind, pla-
cebo controlled, multicenter trial, the initial total cholesterol
of patients was equal to or more than 280 mg/dL. Patients
received 1.8 mg/day artichoke dry extract (n¼ 172) or placebo
(n ¼ 171) for 6 weeks. Total cholesterol was decreased 18.5%
in the drug group versus 8.6% decrease in the placebo group;
low-density lipoprotein cholesterol by 23% versus 6%; and
low-density lipoprotein to high-density lipoprotein ratios by
20% versus 7%. Compounds present in the leaf of artichoke
like cynarin and luteolin may play a significant role in reducing
the synthesis of cholesterol as well as its total level.26
Dosage. According to Germany’s Commission E, 6 g of the
dried herb or its equivalent (totally 3 times per day) is the
optimal dose to treat dyspepsia. However, the optimal dose for
hyperlipidemia is not mentioned.27
Toxicity. No side effect has been observed in using leaves of
artichoke so far, but since investigations in this regard are not
complete, pregnant or nursing women are recommended not
to use it. Also, young children or people with severe liver or
kidney disease and individuals with gallstones should use
the leaves with caution. Individuals with allergies to arti-
choke or similar plants (Asteraceae family) such as arnica
or chrysanthemums should avoid using artichoke or cynarin
preparations.27
Medicago sativa (Alfalfa)
In traditional medicine, Medicago sativa is used as a dietary
supplement, antidiabetic, antihyperlipidemic, and anti-allergen.
It is also used to treat menstrual disorders, gastrointestinal tract
disorders, kidney and urinary tract problems, burns, and arteritis.
This plant is used as a dietary supplement, thanks to it containing
high amounts of b-carotene and vitamins, including B, C, E, and
K. Researches have suggested that seeds of Medicago sativa
have the ability to decrease the blood cholesterol level in labora-
tory animals. Using seeds of this plant in monkeys for 1 year not
only suggested no side effects but also reduced the blood choles-
terol level.28
In this study in which the effects of alfalfa on aortas from
cynomolgus monkeys with diet-induced atherosclerosis were
evaluated, alfalfa resulted in varied degrees of regression of
lesions. The results also showed that mean hydroxyproline as
well as total glycosaminoglycan concentration in aortas was
correlated with the severity of the lesions (P < .05). These
observations suggest that connective tissue components are
intimately involved in remodeling the aorta during regression
of diet-induced atherosclerosis.28
Laboratory studies have reported the presence of plant estro-
gens in this plant that may be useful to treat menstrual disor-
ders. This plant is also used to treat pollinosis but clinical
studies have not determined the effectiveness of this plant in
the treatment of this disease.28,29
Dosage. In traditional medicine, 1 to 2 spoons of the powder of
leaves or plant seeds that are infused in boiled water for 10 to
20 minutes are used. Pill or capsule of the plant should be used
according to the instruction of the manufacturer.29
Restrictions. Due to estrogenic effects existing in some com-
pounds of this plant, pregnant and nursing women or children
should not use this drug.29
Drug Interaction. Due to high amount of vitamin K in this plant,
the effects of wafarin in individuals who use this plant may
decrease if it is used along with warfarin.30
Toxicity. Powder of plant and seeds of Medicago sativa contain
L-cavanin, a substance that may cause disorder in blood cells
and lead to the splenomegaly.30
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Trigonella foenum graecum L (Fenugreek)
In traditional medicine, Trigonella foenum graecum L is pre-
scribed to treat diseases like diabetes, high cholesterol, bron-
chitis, constipation, dyspepsia, and renal problems. Studies
conducted on laboratory animals and clinical studies suggest
that this plant decreases the level of blood sugar in diabetic
patients and lowers blood cholesterol. This plant like other food
products containing high fiber can be useful to treat constipa-
tion. Twenty-five individuals with type 2 diabetes mellitus,
in 2 drug (1 g of the extract per day) and placebo groups, were
compared in a 2-month period. The level of blood sugar
decreased significantly in the drug group compared with the
placebo group, and the level of triglyceride decreased and
high-density lipoprotein level increased in this group.30,31
Other animal and human studies have also suggested that
fenugreek ameliorates blood triglycerides, total cholesterol,
and low-density lipoprotein. It also prevents low-density lipo-
protein from oxidation, which is one the major components
of atherosclerosis induction. These effects have been attributed
to the plant’s sapogenins and phytoestrogens. Sapogenins have
been shown to increase biliary cholesterol excretion, and phy-
toestrogens indirectly increase thyroid hormones.31
Dosage. The usual dosage is 5 to 30 g of the plant seed powder
3 times per day in the meal time.31
Toxicity. This plant has mild gastrointestinal tract stimulatory
effect, if it is used in high dose. No toxic effect was observed
in animal studies as a result of eating this plant. The extract
obtained from seed of Trigonella foenum graecum L has cre-
ated the stimulatory effect on uterus of guinea pig. For this
reason, pregnant women are recommended to avoid eating this
plant, and it should not be used by children and patients with
renal and liver diseases.30
Drug Interaction. Seed of Trigonella foenum graecum L intensi-
fies the effect of insulin or other blood sugar-lowering drugs
due to blood sugar lowering property.30
Allium sativum L
Allium sativum L (garlic) is used in the treatment of an exten-
sive range of diseases. The aromatic compound alliin is one of
the most important compounds that exist in Allium sativum L.
When garlic is cut or pressed, an enzyme named Alinase affects
alliin, transforming it to allicin, which is the main factor of the
strong odor of the garlic.32 Today, garlic is used to treat gastro-
intestinal tract disorders, asthma, diabetes, cardiovascular dis-
eases, hypercholesterolemia, common cold, and high blood
pressure.33 Although it is stated that using this plant decreases
cholesterol and blood pressure, there are contradictive scien-
tific evidences in this regard. Although some studies performed
over the 1980 to 1990 decades suggested that garlic can
decrease the blood cholesterol level, some more recent studies
have shown contrary results.4,33,34
In a clinical study, taking the garlic capsules for 12 weeks,
the compound was able to decrease cholesterol and low-density
lipoprotein significantly in 46 patients with high blood choles-
terol.35 In this clinical trial, following 12 weeks of garlic sup-
plement (n ¼ 22), the total cholesterol and low-density
lipoprotein cholesterol levels significantly decreased, while
these parameters were not statistically changed in the placebo
group (n ¼ 24). In this study, no significant difference was
observed in triglycerides or in low-density lipoprotein/high-
density lipoprotein ratio between groups. The authors con-
cluded that enteric-coated garlic supplements, with 9.6 mg
allicin-releasing value, has potential to ameliorate the lipid pro-
file of patients with mild to moderate hypercholesterolemia
when they are recommended to have low-fat diet. Taken with
other evidence, the ability of garlic extract for reduction of
hypercholesterolemia might be attributed to allicin bioavail-
ability, that is, greater anticholesterolemic efficacy might be
evident at a higher allicin level.35
Effect of Garlic on Atherosclerosis and Aorta Elasticity. Primary
information has suggested that garlic may be effective in inhi-
biting atherosclerosis formation, which is an important factor
of cardiovascular diseases. It has been reported that garlic
decreases formation of the atherosclerosis plaque in laboratory
animals.4 In a clinical study performed on 152 individuals,
using 900 mg of garlic powder daily for 4 years decreased for-
mation of the atherosclerosis plaques significantly.36 In other
clinical study performed on 200 individuals, the positive effect
of the garlic in decreasing the formation of atherosclerosis
plaque was observed.37 In this study, healthy adults (n ¼
101; age ¼ 50 to 80 years, matched with the same number in
the control group) were administered 300 mg/day of garlic
powder for at least 2 years. Pulse wave velocity, elastic vascu-
lar resistance, and pressure were used to measure the elastic
properties of the aorta. The heart rate, blood pressure, and lipid
profile were similar in the 2 groups. The pulse wave velocity
(P < .0001) and elastic vascular resistance (P < 0.001) were
lower in the garlic group than in the control group. Pulse wave
velocity showed significant positive correlation with systolic
blood pressure and age. Analysis of covariance and multiple
regression analyses demonstrated that age and systolic blood
pressure were the most important determinants of pulse wave
velocity and that the effect of garlic on pulse wave velocity was
independent of confounding factors. The authors concluded
that garlic intake would protect the effect of the elastic proper-
ties of the aorta related to aging in humans.37
Dosage. The usual consumed dose of garlic powder is 900 mg
daily that contains 1.3% alliin, that is, about 12 mg alliin daily.
The most suitable proposed dose that has been obtained over
clinical studies is about 10 mg alliin, which produces approxi-
mately 4 to 5 mg allicin. Using 1 to 7 g of alliin-free garlic daily
has properties of fresh garlic.36
Toxicity.Using 2000 mg/kg body weight for 6 months created no
negative phenomenon in rats. The most common side effect of
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garlic is its undesired odor. Other side effects are observed
rarely. For example, a study was performed on 1997 individu-
als who used normal dose of odorless garlic for 16 weeks.
Nausea was seen in 6% of them, vertigo in about 1.3% (may
be due to blood pressure decrease), and allergy in 1.1%.
Limited reports also have been stated about headache, vertigo,
hyperidrosis, and tympanites.32
Glycine max (Soybean)
Soya as a food product rich in protein is used in Asia and as
free-cholesterol meat in traditional food of American people.
The American Food and Drug Administration has allowed pro-
ducers of food products containing soybean to use the healthy
heart label on their products. In traditional medicine, soybean
has been used to decrease blood cholesterol and also as an
anticancer and anti-osteoporosis drug.32
The Therapeutic Consumption of Soybean. Several studies have
suggested that soybean can decrease low-density lipoprotein
in the blood. In a study performed on 38 individuals with high
blood cholesterol, soybean decreased blood cholesterol and
improved the low-density lipoprotein/high-density lipoprotein
ratio. In this meta-analysis study the effect of soy protein intake
was evaluated on serum lipid profile of hyperlipidemic
patients. In most of the evaluated trials, the intake of choles-
terol, fat, saturated fat, and energy was nearly equal in the con-
trol and soy-containing diet groups. The average soy protein
intake was 47 g/day. Consumption of soy protein was associ-
ated with average changes in serum lipid profile as follows: a
decrease of 23.2 mg/dL or 9.3% in cholesterol, a decrease of
21.7 mg/dL or 12.9% in low-density lipoprotein cholesterol,
a decrease of 13.3 mg/dL or 10.5% in triglycerides. The inges-
tion of soy protein was associated with a nonsignificant 2.4%
increase in serum concentrations of high-density lipoprotein
cholesterol. The author concluded that consumption of soy pro-
tein is beneficial in hypercholesterolemic patients. Thus, soy
protein rather than animal protein was able to significantly
decrease the serum concentrations of triglycerides, total choles-
terol, low-density lipoprotein cholesterol.38 Some observations
indicate that isoflavones available in soybean have an impor-
tant role in decreasing blood cholesterol but some studies refute
this. Moreover, proteins available in soybean may have more
an important role compared with these flavones.3
Dosage. The US Food and Drug Administration recommends
25 g of soybean protein to decrease blood cholesterol, although
consuming higher dose is more effective. Observations suggest
that replacing 20 g of soy protein with meat protein decreases
blood cholesterol significantly. Some studies prescribe 40 g
daily.32
Drug Interaction. Soy may decrease the effect of thyroid drugs.
Moreover, several evidences show that soy isoflavones can
inhibit the performance of the thyroid gland, although this state
may be only significant in individuals with iodine deficiency.
Of course, some studies also reject the effect of soy and its iso-
flavones on thyroid hormones. Finally, individuals with thyroid
problems are recommended to avoid high amounts of soy. Soy
can decrease absorption of iron, calcium, and zinc. To compen-
sate this state, materials containing these compounds should be
used 2 hours after the consumption of soy.32
Toxicity. Although soy and its isoflavones can cause harmful
effects in some conditions, animal studies have suggested that
soy has no toxic effect.18 Clinical studies suggest that soy
decreases the level of the testosterone hormone in men. More-
over, some studies indicate the presence of estrogenic property
in soy isoflavones. For this reason, use by pregnant women can
lead to embryo damage.32
Silybum marianum L
The main components of Silybum marianum L extract is known
as silymaryne. Silimaryne, consisting of 4 compounds includ-
ing sylymarin, is a herbal drug with hepatoprotective properties
and contains different compounds like flavonoids with antiox-
idant, cellular membrane stabilizing, and blood glutathione
increasing properties, and its positive effect in improving dif-
ferent diseases including hyperlipidemia have been reported
in laboratory studies.39-41 Results of the clinical researches
indicate that silimaryne can be presented as a blood cholesterol
reducer in patients with hypercholesterolemia. Using 420 mg
of silimaryne once a day decreased cholesterol concentration
in bile in 15 patients with high blood cholesterol compared
with the control group, indicating that cholesterol synthesis
decreases in the liver.42 In a clinical study performed on 14
patients with hypercholesterolemia type 2, silimaryne at a dose
of 420 mg decreased the total cholesterol level and increased
the blood high-density lipoprotein level. In a clinical study,
administration of silimaryne to diabetic patients with the hyper-
lipidemia decreased the total cholesterol, low-density lipopro-
tein, and triglyceride levels.42
Red Yeast Rice
Red yeast rice is an important foodstuff in the daily diet of
Chinese people. This is native to China and is the secondary
product that results from the fermentation of a kind of cooked
rice that red yeast rice has grown on it. This material is pre-
scribed in traditional Chinese medicine as blood circulation and
food digestion stimuli.43 It has been reported that prescription
of red yeast rice decreases blood cholesterol, and this effect
is attributed to the statins available in this material. Statins are
prescribed as blood cholesterol lowering drugs. Red yeast rice
contains some active compounds including monacolin K,
dehydromonacolin, and monacolin I-VI in addition to starch,
protein, fiber, sterols, and fatty acids. Researchers have stated
that one of the components of this yeast, monacolin K, inhibits
production of cholesterol via stopping the activity of the HMG-
CoA reductase enzyme, which has an important role in choles-
terol synthesis. Statins are a class of hypocholesterolemic drugs
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that reduce cholesterol levels by inhibition of HMG-CoA
reductase in the liver. This enzyme is responsible for the pro-
duction of more than 70% of total cholesterol in the body.44
Although the amount of monacolin K in red yeast rice is
lower than lovastatin (2% in 5 mg vs 20-40 mg), it acts simi-
larly. For this reason, researchers have proposed that red yeast
rice contains other compounds like sterols that possibly have a
role in decreasing cholesterol.44 In addition to laboratory stud-
ies on animals, red yeast rice has been studied clinically in
order to study its cholesterol-lowering effect. In a study,
patients used daily 1.2 g of the concentrated extract of yeast
(containing approximately 13.5 mg monacolin) for 2 months.
In this study, significant decrease in the total serum cholesterol
level was observed. Moreover, serum high-density lipoprotein
level in these people increased and the low-density lipoprotein
and triglyceride levels decreased.45
Dosage. A product called colistin obtained from this yeast has
entered into the China market and its dosage is 1.2 to 2.4 g daily
with divided doses for 8 to 12 weeks.43
Restrictions. People with liver disorders and pregnant women
should not use red yeast rice. With regard to the similar effect
of red yeast rice and statin drugs, they should be used together
under the supervision of a physician.43
Toxicity. Usually, consumption of this material is tolerable and
generally has no side effects, but some effects like heart burn
and mild vertigo have been observed.45
Commiphora mukul (Guggul, Gugulipid)
Commiphora mukul is an adhesive gum that is obtained from
the Mukul myrrh tree. In the traditional medicine of India, this
material is combined with other plants and is applied to treat
skin problems, nervous system pains, obesity, diabetes, diges-
tive problems, rheumatoid pains, mouth infection, and men-
strual problems.46 To study the effect of this material on
blood cholesterol, a study on 61 individuals was performed for
24 weeks. After 12 weeks of diet control, half of the individuals
received placebo and other half received Guggul at 100 mg
daily dose. After 12 weeks, the total cholesterol level decreased
11.7%, low-density lipoprotein level 12.7%, triglyceride 12%,
and cholesterol-high-density lipoprotein ratio 11.1% in individ-
uals who used Guggul, which was significant compared with
the placebo group.47 Moreover, a double-blind study per-
formed on 228 individuals indicated similarity of this mat-
erial’s effect with that of clofibrate.48 This multicentric,
double-blind, crossover study was completed in 125 patients
with Guggul and in 108 patients with clofibrate. None of the
patients in the Guggul group showed significant side effect
except one patient who showed some gastrointestinal symp-
toms, but not severe enough to necessitate withdrawal of the
drug. Two patients in the clofibrate group showed flu-like
syndrome and opted out of the study. In this clinical trial, which
was conducted at Bombay and Bangalore, India, patients
consumed Commiphora mukul in a dose of 500 mg 3 times per
day for 12 weeks. The results showed a significant reduction in
serum triglycerides (average 22.6%) and serum cholesterol
(average 23.6%) in 70% to 80% of patients who consumed
gugulipid. The average reduction in serum triglycerides and
cholesterol was 16.8% and 11%, respectively, in patients who
consumed with clofibrate. The lipid-lowering effect of both
drugs became evident 3 to 4 weeks following the start of the
drug. In this study, hypertriglyceridemic patients responded
better to clofibrate; however, hypercholesterolemic patients
responded better to gugulipid therapy. Clofibrate had no effect
on high-density lipoprotein; however, high-density lipoprotein
was increased in 60% of cases who consumed gugulipid. A sig-
nificant reduction in low-density lipoprotein cholesterol was
observed in the responders to both drugs.48
Dosage. Dosage depends on Guggul concentration and the level
of the blood lipid, and usually 100 mg daily is prescribed.46
Toxicity. In clinical studies, no significant side effect has been
reported after the administration of the standard extract of Gug-
gul. Liver, renal, heart, and biochemical experiments indicate
safe consumption of this material.46
Dietary Plants Fibers With Hypolipidemic
Activity
Dietary fibers are complex carbohydrate polymers with plant
origin that are composed of simple sugars and generally are
classified based on solubility.49 Soluble fibers are made up of
sticky substances like gum pectin and mucilage that are readily
consumed by the bacteria in colon. Insoluble fibers consist of
structural and/or matrix fibers such as lignin, cellulose, and
hemicellulose, which are digested without change. Useful
effects of dietary fibers in lowering blood lipids have been
reported in clinical and laboratory researches.49
Plantago psyllium
Plantago psyllium is water-soluble fiber derived from Plantago
ovate seed husk. In a study conducted on individuals with
hypercholesterolemia, 6 to 8 weeks of psyllium treatment
decreased total cholesterol by 3.5% to 5.6% and low-density
lipoprotein cholesterol by 5.1% to 8.8% compared with pla-
cebo treatment. In an experiment on 125 individuals with type
2 diabetes and hyperlipidemia, 5 g psyllium seed was taken 3
times per day for 6 weeks. In these patients, in addition to
decrease in the blood glucose level, the total cholesterol,
low-density lipoprotein cholesterol, and plasma triglyceride
levels decreased after 2 weeks of treatment, while the high-
density lipoprotein cholesterol level increased.50
In this study, the hydrophilic mucilloid of psyllium was
examined in 75 hypercholesterolemic patients for its ability
to lower serum cholesterol. Patients with mild to moderate
hypercholesterolemia were included in this double-blind, ran-
domized, placebo-controlled parallel trial. In step I, the patients
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were treated with a diet for 12 weeks before receiving placebo
or 3.4 g of psyllium 3 times/day for 8 weeks. Reported adher-
ence to diet and treatment was high, and no significant adverse
side effects were noted. In comparison to placebo, psyllium
achieved an additional 4.8% reduction in total cholesterol
level, 8.2% reduction in low-density lipoprotein cholesterol
level, and 8.8% reduction in apolipoprotein B level, with no
significant effect on blood pressure, serum glucose, or levels
of triglycerides, high-density lipoprotein, or iron. The authors
concluded that the hydrophilic mucilloid of psyllium was an
effective and well-tolerated adjunct to diet in the management
of mild to moderate hypercholesterolemia.51
Use in Pregnancy and Breast-feeding.No harmful side effects have
been observed as a result of using the Plantago ovate seed or its
seed husk, if the usual dose is used during pregnancy and breast
feeding.51
Drug Interaction. Insulin-dependent diabetic patients may need
to reduce the irinsulin dosage while using plantago ovate seed.
The drug interaction between plantago ovate seed with lithium
and carbamazepine has been reported. The simultaneous use of
drug and plantago ovate seed may cause problems in drug
intake. So it is recommended to use the seed of this plant ½
to 1 hour after the use of the drug. Plantago ovate seeds that are
used mainly as emollient may cause subcutaneous emphysema.
A large amount of water (not juice or other liquids) should be
used to maintain the levels of water excreted. If there is no
external water, plantago ovate seed absorb the water from wet
mucous membrane of the gastrointestinal tract, which may lead
to the damage of a part of bowel that is accompanied by inten-
sive abdominal pain.51
Dose. The dose is 5 to 15 g of the seed husk but administration
of 5 g of the seed husk to decrease the glucose level and blood
lipid has been stated in a report.52
Cyamopsis retragonoloba (Guar Gum)
Guar gum is the nutrient derived from the edible seed of the
Cyamopsis retragonoloba plant, which is an ingenuous plant
of Asian countries. Laboratory studies showed that administra-
tion of guar gum to rat decreased the blood cholesterol level
significantly in these animals. This effect was attributed to the
effect of this dietary fiber on enterohepatic circulation. It has
been stated that guar gum also decreases the fat intake available
in foods by affecting the microflora of the gastrointestinal
tract.53 In addition, reports presented in other researches indi-
cate that the lowering of blood cholesterol by guar gum is pos-
sibly due to the increase of steroids’ excretion in feces and also
increase of bile production.54 It has been reported that admin-
istration of guar gum decreases appetite and in addition
decreases cholesterol and triglyceride levels, and as a result
weight of laboratory animals is decreased. In clinical studies
also administration of guar gum to individuals with type 2
diabetes and hyperlipidemia decreased sugar and blood lipid
levels.54
Dose. A dose of 15 g daily should be used to decrease
cholesterol.27
Oat
Oats as a foodstuff containing high fiber, in addition to differ-
ent nutritional properties, can decrease the blood cholesterol
level. In a study, 152 patients whose low-density lipoprotein
levels was between 120 and 190 and triglyceride levels lower
than 400 were fed oat diet for 6 weeks and the total cholesterol
and low-density lipoprotein levels decreased.53 A study
showed that diet containing oat has a positive effect on body
metabolism of women who are overweight. Using oat also led
to decrease in the cholesterol level and low-density lipoprotein
levels of individuals with hyperlipidemia in this study. More-
over, it has been stated that antioxidant properties of oat inhibit
low-density lipoprotein oxidation, dose-dependently.54
Dose. Dose for individuals with hyperlipidemia has been
reported to be 28 g/day.27
Discussion
Hyperlipidemia has been shown to affect the antioxidant status
of different organs as well as their lipoprotein levels.55-57
Lipid-lowering medicinal plants may reduce hyperlipidemia,
preventing atherosclerosis and vascular endothelium dam-
age.58,59 In most cases this effect and even the other effects
of medicinal plants, at least in part, have been attributed to their
antioxidant properties.60-63
Hyperlipidemia increases the production of free radicals,
which in turn increases oxidative stress and low-density lipo-
protein oxidation. During this process, low-density lipoprotein
converts to oxidized low-density lipoprotein, induces the
expression of adhesion molecules, stimulates activation of T
cells and macrophages, increases the production of foam cells,
and attracts macrophages to the sarcoplasmic reticulum. Oxida-
tion of low-density lipoprotein has a crucial role in the forma-
tion of atherosclerotic plaques.64,65
Initially, lipophilic antioxidants preserve low-density lipo-
protein particles against deformation, but in case of antioxidant
deficiency unsaturated fatty acids will be oxidized. In this step
of oxidation, low-density lipoprotein particles usually undergo
slight changes. However, if this step continues and causes more
accumulate of lipid oxidation products, these components start
reacting with amino acids of ApoB-100 protein and cause cova-
lent bond formation, resulting in increase in degradation of
their protein part of low-density lipoprotein.66-68
Ox-low-density lipoprotein has a wide variety of effects
such as chemokine expression, monocytes proliferation,
chemotaxis of monocytes, fat cells formation, inhibition of
macrophages movement, expression of endothelial adhesion
molecules, growth factor stimulation,69 fatty streaks formation,
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and thickening of intima. All of these changes are effective in
the progress of atherosclerosis.70-73
Inflammation is also related to coronary artery diseases. For
example, C-reactive protein, which reflects extravascular
inflammation, is increased in atherosclerosis and its complica-
tions.7 It has been shown that patients with high C-reactive pro-
tein levels are also more prone to hypertension and diabetes
mellitus, and both of these are related to atherosclerosis.74
Reduction of free radicals by plants antioxidants, therefore,
which scavenge free radicals and reduce oxidative stress, apart
from reducing hyperlipidemia, can reduce the possibility of
atherosclerosis.
Antioxidants such as beta-carotene, selenium, and vitamins
C and E were considered as being able to prevent cell mem-
brane oxidation.75,76 However, recently their widespread use
has been recommended to be limited because of their toxic
effects or being ineffective. Therefore, natural compounds with
antioxidant activity, which mostly have low toxic effects, seem
to have beneficial effects.
In this regard, the Food and Nutrition Board decreased the
recommended dietary allowance for some of these agents.
Since the last report of the recommended dietary allowance,
in 1989, the Food and Nutrition Board has changed the criteria
for establishing recommended dietary allowances from preven-
tion of deficiency diseases to prevention of chronic diseases.
However, the revised recommended dietary allowances by the
Panel on Dietary Antioxidants and Related Compounds of the
Food and Nutrition Board were not based on the prevention of
chronic diseases but based primarily on the prevention of defi-
ciency symptoms. Hence, the new recommended dietary allow-
ances for dietary antioxidants were different from the
recommended dietary allowances published in 1989. The new
recommended dietary allowances for adults are as follows:
vitamin C, 75 mg/day for women and 90 mg/day for men; vita-
min E, 15 mg/day or 22 IU for women and men; and selenium,
55 mg/day for women and men.77
The Panel considered the possibility that intakes higher than
the recommended dietary allowances might prevent chronic
diseases, but concluded that there were insufficient data to
prove that increased intake of antioxidants exert beneficial
health effects beyond the prevention of deficiency symptoms.
The Panel established values for the upper intake level for diet-
ary antioxidants too. The upper intake level is defined as ‘‘the
highest level of daily nutrient intake that is likely to pose no
risk of adverse health effects to almost all individuals in the
general population.’’ The upper intake levels for adult men and
women are the following: 2 g/day for vitamin C, 1000 mg/day
for vitamin E, and 400 mg/day for selenium.77
Herbal medicine extracts mostly have antioxidant proper-
ties.78-81 Therefore, as a source of different antioxidants, they
can be very effective in modulating oxidative stress, thus
protecting different organs such as heart,10 kidney,82-86 and
live,87-89 from oxidative damages.90-92
Although different components of plants can have antioxi-
dant effects, the main part of such effects is attributed to phenol
compounds.93-95 A lot of medicinal herbs such as Ocimum
basilioum, Allium sativum, Silybum marianum, Anethum
graveolens, Boswellia carterii, Juglans regia, Trigonella foe-
num-graecum, Berberis vulgaris, Nigella sative, Sesamum
indicum, Aloe vera, Ziziphus jujube, and Zingiber officinale
possess antioxidant activities thanks to their phenolic com-
pounds.18,66,96-102 Some of these plants have been examined for
their hypolipidemic activities and the others are worth
examining.
Conclusion
Today, hyperlipidemia and its resultant side effects have been
known as one of the medicinal problems in most societies.
Hyperlipidemia, in addition, intensifies metabolic disturbances
and increases the risk of cardiovascular diseases, especially in
patients with diabetes and blood pressure. Available informa-
tion indicates that compounds available in food supplements
and medicinal plants including dietary fibers, vitamins, flavo-
noids, sterols, and other antioxidants can be effective for the
metabolism of lipids by influencing the metabolic reactions
of different tissues. In most cases the lipid-lowering properties
of these plants, at least in part, have been attributed to their
antioxidant properties, and a lot of medicinal plants possess
antioxidant properties.103-106 Therefore, it might be useful to
examine other medicinal plants that have antioxidant activities
for their hypolipidemic activities.
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